Effects of the peripheral CB<sub>1</sub> receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.

Remiszewski, Patryk; Pedzinska-Betiuk, Anna; Minczuk, Krzysztof; Schlicker, Eberhard; Klimek, Justyna; Dzieciol, Janusz; Malinowska, Barbara

Effects of the peripheral CB₁ receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.

Remiszewski, Patryk; Pedzinska-Betiuk, Anna; Minczuk, Krzysztof; Schlicker, Eberhard; Klimek, Justyna; Dzieciol, Janusz; Malinowska, Barbara.

Afiliação

Remiszewski P; Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Bialystok, Poland.
Pedzinska-Betiuk A; Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Bialystok, Poland.
Minczuk K; Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Bialystok, Poland.
Schlicker E; Department of Pharmacology and Toxicology, University of Bonn, Bonn, Germany.
Klimek J; Department of Human Anatomy, Medical University of Bialystok, Bialystok, Poland.
Dzieciol J; Department of Human Anatomy, Medical University of Bialystok, Bialystok, Poland.
Malinowska B; Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Bialystok, Poland.

Front Pharmacol ; 13: 965613, 2022.

Article em En | MEDLINE | ID: mdl-36120288